| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Corp Strategy &Develop
1 company
Laplume Joseph W is an EVP, Corp Strategy &Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Recent SEC Form 4 filings include 0 buys and 23 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2023 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 345 | $190.39 | $65,684.55 | -1.4% | +12.8% | +21.0% | |
| May 12, 2023 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 959 | $193.03 | $185,115.63 | -1.9% | +13.8% | +19.3% | |
| Dec 1, 2022 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sale+OE | 6,409 | $224.25 | $1,437,204.80 | -8.7% | -1.5% | -10.8% | |
| Nov 4, 2022 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 534 | $216.36 | $115,536.24 | -2.6% | +18.0% | -17.4% | |
| Aug 5, 2022 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 200 | $226.13 | $45,226.82 | -1.0% | -2.8% | -7.4% | |
| Feb 23, 2022 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 395 | $292.75 | $115,636.25 | -2.0% | -21.2% | -19.9% | |
| Feb 22, 2022 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sale+OE | 1,539 | $291.55 | $448,697.57 | -2.4% | -20.1% | -24.3% | |
| Aug 6, 2021 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 3,700 | $402.21 | $1,488,175.19 | -8.9% | -7.1% | -45.3% | |
| Feb 25, 2021 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sale+OE | 8,735 | $281.70 | $2,460,614.99 | -13.6% | - | - | |
| Nov 4, 2020 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sale+OE | 6,739 | $250.28 | $1,686,627.27 | -13.9% | - | - |